Skip to main content
OpenTrials

Clinical trial condition

Rheumatic Diseases

Explore clinical trials studying Rheumatic Diseases. Study availability and eligibility vary by location and protocol.

8,083 public trials 949 recruiting studies
Refine in advanced search Browse all conditions

Rheumatic Diseases trial results

Completed

A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis

NCT00814307

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site Gilbert, Arizona, United States
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Hot Springs, Arkansas, United States
  • Pfizer Investigational Site Jacksonville, Florida, United States
View all 95 locations
View Trial Details
Completed

Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

NCT00413660

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site Gilbert, Arizona, United States
  • Pfizer Investigational Site Hot Springs, Arkansas, United States
  • Pfizer Investigational Site Upland, California, United States
  • Pfizer Investigational Site Denver, Colorado, United States
View all 82 locations
View Trial Details
Completed

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

NCT00853385

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Pfizer Investigational Site Gilbert, Arizona, United States
  • Pfizer Investigational Site Glendale, Arizona, United States
  • Pfizer Investigational Site Mesa, Arizona, United States
  • Pfizer Investigational Site Paradise Valley, Arizona, United States
View all 125 locations
View Trial Details
Completed

A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications

NCT00856544

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site Huntsville, Alabama, United States
  • Pfizer Investigational Site Jonesboro, Arkansas, United States
  • Pfizer Investigational Site Palo Alto, California, United States
  • Pfizer Investigational Site Stanford, California, United States
View all 133 locations
View Trial Details
Completed

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

NCT00976599

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site La Jolla, California, United States
View all 15 locations
View Trial Details
Completed

Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

NCT00663169

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Novartis Investigator Site Birmingham, Alabama, United States
  • Novartis Investigator Site New Brunswick, New Jersey, United States
  • Novartis Investigator Site Lausanne, Switzerland
  • Novartis Investigator Site Glasgow, United Kingdom
View Trial Details

Related conditions